Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

Prevention of chemotherapy-induced peripheral neuropathy: a matter of personalized treatment?

(2013) T. J. Postma et al.   ANNALS OF ONCOLOGY

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention

(2012) W. Grisold et al.   NEURO-ONCOLOGY

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

(2012) Sherry L. Wolf et al.   SUPPORTIVE CARE IN CANCER

Impact of oxaliplatin-induced neuropathy: a patient perspective

(2012) Barbara K. Bennett et al.   SUPPORTIVE CARE IN CANCER

Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations

(2011) T. Luckett et al.   ANNALS OF ONCOLOGY

Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer

(2011) Naohiko Inoue et al.   International Journal of Clinical Oncology

Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

(2011) Barbara Frigeni et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy

(2010) Dawn L. Hershman et al.   BREAST CANCER RESEARCH AND TREATMENT

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies

(2008) S I van Nes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY